Live Breaking News & Updates on Protein Functional Data

Ambry Genetics to Present at 2021 ACMG Annual Clinical Genetics Meeting
Study shows strong data for finding whether certain genetic variants in the BRCA2 cancer gene may be classified as disease-causing
News provided by
Share this article
Share this article
ALISO VIEJO, Calif., April 13, 2021 /PRNewswire/ Ambry Genetics  Corporation (Ambry), a Konica Minolta Precision Medicine (KMPM) company and a leader in clinical diagnostic testing, announced it will be presenting 
The Uniform Application of Protein Functional Data has an Impressive Potential to Resolve VUS Rates in BRCA2 based on a study published in
The American Journal of Human Genetics
 in collaboration with researchers at the Mayo Clinic, Moffit Cancer, and the University of Utah. Ambry will present an overview of findings at the 2021 ACMG Annual Clinical Genetics Meeting. ....

Rachid Karam , Brigette Tippin Davis , Marcy Richardson , Corporation Ambry , University Of Utah , Konica Minolta Company , Konica Minolta Precision Medicine , Uniform Application , Protein Functional Data , Impressive Potential , American Journal , Human Geneticsin , Mayo Clinic , Moffit Cancer , Clinical Genetics , Variant Assessment , Fergus Couch , Chief Scientific Officer , Ambry Genetics , ராச்சிட் கரம் , மார்சி ரிச்சர்ட்சன் , பல்கலைக்கழகம் ஆஃப் உட்டா , கொநிக மினோல்டா நிறுவனம் , கொநிக மினோல்டா ப்ரிஸிஶந் மருந்து , சீருடை விண்ணப்பம் , அமெரிக்கன் இதழ் ,